American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
Combined nonmyeloablative total lymphoid irradiation and low-dose total body irradiation enhances donor chimerism and leads to islet allograft acceptance.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pathak Shiva, Iliopoulou Bettina P, Mosher Blake, Wells Alexandra, Witherspoon Levon, Bader Cameron S, Chen Pin-I, Regmi Shobha, Gupta Biki, Dutt Suparna, Wu Xiangni, Nagy Nadine, Jensen Kent P, Thakor Avnesh S, Strober Sam, Lowsky Robert, Meyer Everett H
Аннотация
The nonmyeloablative conditioning regimen comprising total lymphoid irradiation (TLI) and antithymocyte globulin is used for allogeneic hematopoietic stem cell transplant patients. There is a need to safely intensify TLI+antithymocyte globulin to allow for the achievement of sustained mixed chimerism, particularly in cases where pre-existing autoimmunity poses a significant barrier to successful engraftment. We developed a nonmyeloablative immune preconditioning protocol using low-dose total body irradiation (TBI) to increase the level and durability of mixed donor chimerism. Non-obese diabetic mice were preconditioned with a modified protocol comprising TLI, low-dose TBI, and antithymocyte serum before bone marrow (BM) transplantation. The incorporation of low-dose TBI resulted in enhanced lymphodepletion and facilitated successful engraftment of allogeneic BM to create mixed donor chimerism. The establishment of mixed donor chimerism led to a long-term acceptance of transplanted pancreatic islets that were matched to the BM. More importantly, third-party islets from donors that were mismatched to both the recipient and BM donors were also accepted, highlighting the potency of tolerance induction using this preconditioning regimen. These results provide strong support for a rapid clinical evaluation of this modified conditioning regimen in the context of post-transplant tolerance induction.